Download our NEW Mobile App!

Patient Resources

  1. Home
  2. Patient Resources
  3. Health Videos

Get Healthy!

Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.

Heart / Stroke-Related: Heart AttackDiabetes: Misc.ObesityHeart / Stroke-Related: StrokeWeight Loss
HealthDay
Health News is provided as a service to Davis Drug site users by HealthDay. Davis Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags

Heart / Stroke-Related: Heart AttackDiabetes: Misc.ObesityHeart / Stroke-Related: StrokeWeight Loss